期刊文献+

原发性胆囊癌中PTEN表达的临床研究 被引量:1

Study on the expression of PTEN in human primary gallbladder carcinoma(HGC)
下载PDF
导出
摘要 目的研究抑癌基因-10号染色体缺失的磷酸酶及张力蛋白同源物基因(PTEN)在原发性胆囊癌(HGC)中的表达,以探讨其在HGC发生发展中的作用,寻找胆囊癌诊断及预后的指标。方法应用原位杂交(DNA-RNA)技术与免疫组化S-P法分别检测64例HGC中PTENmRNA、PTEN蛋白的表达。以22例胆囊腺瘤及10例慢性胆囊炎作为对照。结果PTENmRNA及蛋白在HGC组织中的阳性表达率(56.3%,59.4%)均明显低于胆囊腺瘤组织(81.8%,90.8%)和慢性胆囊炎组织(100%,100%;P<0.05)。结论PTEN低表达参与了HGC的发生发展,PTEN与HGC分化、转移有关,其蛋白可作为判断HGC预后的指标。 Objective To study the expression of phosphatase and tensin homology deleted on chromosome ten(PTEN) and analyse its roles in HGC oncogenesis,and to discover good marker for diagnosis and prognosis of HGC. Methods The expression of PTEN mRNA and PTEN protein were examined by in situ hybridization(DNA-RNA) and immunohistochemistry( SP method)respectively in 64 cases of HGC. Twentytwo cases of gallbladder adenoma and 10 cases of chronic cholecystitis were taken as control, Results The positive expression rates of PTEN mRNA and protein in HGC(56, 3% ,59, 4% ) were significantly lower than those in gallbladder adenoma (81.8 % ,90.8 % ) and chronic cholecystitis ( 100%, 100% ), P 〈 0. 05, Conclusion PTEN may play important role in HGC oncogenesis. The expression of PTEN is related to the differentiation and metastasis of HGC, and may be amarker for prognosis evaluation.
作者 黄英 郑长黎
出处 《中国肿瘤临床与康复》 2007年第1期14-16,共3页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 胆囊肿瘤 PTEN 免疫组织化学 Gallbladder neoplasms PTEN Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献25

  • 1Li J,Yen C,Liaw D, et al .Science, 1997,275:1943-1947.
  • 2Steck PA,Pershous MA,Japer SA, et al .Nat Genet,1997,15:356.
  • 3Li DM,Sun H.Cancer Res, 1997,57:2124-2129.
  • 4Myers MP, Stolarov JP, Eng C, et al . Proc Natl Acad Sci USA, 1997,94: 9052-9057.
  • 5Furnari FB,Lin H, Huang H, et al. Proc Natl Acad Sci USA,1997,94:12479-12484.
  • 6Robertson GP, Furnari FB,Miele ME, et al .Proc Natl Acad Sci USA,1998,95: 9418-9423.
  • 7Kulik G,Weber MJ.Mol Cell Bio1,1998,18:6711-6718.
  • 8Maehama T, Dixon JE.Trends Cell Bio1,1999,9(4):125-128.
  • 9Davies MA,Koul D, Dhesi H, et al .Cancer Res, 1999,59:2551-2556.
  • 10Besson A,Robbins SM,Yong VW. Eur J Biochem,1999,263(3):605.

共引文献2

同被引文献12

  • 1Takahashi C, Sheng Z, Horan TP, et al. Regulation of matrix metaUoproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK[]]. Proc Nad Acad Sci U S A, 1998, 95(22): 13221-13226.
  • 2Takenaka K, Ishikawa S, Kawano Y, et al. Expression Of a novel matrix metalloproteinase regulator, RECK, and its clinical significance in resected non-small cell lung cancer[J]. Eur J Cancer, 2004, 40(10): 1617-1623.
  • 3Noda M, Oh J, Takahashi R, et al. RECK: a novel suppressor of malignancy linking oncogenic signaling to extracellular matrix remodeling[J]. Cancer Metastasis Rev, 2003, 22(2-3): 167-175.
  • 4Sasahara RM, Brochado SM,Takahashi C, et al. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene[]]. Cancer Detect Prey, 2002, 26(6): 435-443.
  • 5Eisenberg l,Hochner H,Sadeh M, et al. Establishment of the genomic structure and identification of thirteen single-nudeotide polymorphisms in the human RECK gene[J]. Cytogenet Genome Res, 2002, 97(1-2): 58-61.
  • 6Span PN, Sweep CG, Manders P, et al. Matrix metalloproteinase inhibitor reversion- inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma[]]. Cancer, 2003, 97 (11): 2710-2715.
  • 7Chang HC, Cho CY, Hung WC. Downreguladon of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer[J]. Cancer Sci, 2007, 98(2): 169-173.
  • 8Masui T, Doi R, Koshiba T, et al. RECK expression in pancreatic cancer: its correlation with lower invasiveness and better prognosis[J]. Clin Cancer Res, 2003, 9(5): 1779-1784.
  • 9Rajapakse N, Kim MM, Mendis E, et al. Carboxylated chitooligosaccharides(CCOS) inhibit MMP-9 expression in human fibrosarcoma cells via down-regulation of AP-1[J].Biochim Biophys Acta, 2006, 1760(12): 1780-1788.
  • 10Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression[J]. Nat Rev Cancer, 2002, 2(3): 161-174.

引证文献1

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部